Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas

Clinical trial NCT04305444 · TERMINATED

Trial details

NCT number: NCT04305444
Sponsor: Zhejiang DTRM Biopharma
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed Chronic Lymphocytic Leukemia Refractory Chronic Lymphocytic Leukemia Diffuse Large B Cell Lymphoma Follicular Lymphoma Richter's Transformation

Start date: 2020-04-24
Primary completion: 2024-12-31
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.